Cardiology Research and Practice / 2016 / Article / Tab 1

Research Article

Coronary Angiography Safety between Transradial and Transfemoral Access

Table 1

Baseline characteristics of patients ().

CharacteristicTransradial CAG (; %)Transfemoral CAG (; %) value

Age (years)51 ± 16.449 ± 14.90.16
Male856 (79.6%)700 (71.7)0.2
Female220 (20.4%)221 (28.3)0.23
Height (cm)166.5 ± 10.8154 ± 8.40.4
Weight (kg)63.6 ± 11.259.2 ± 9.60.18
BMI (kg/m2)24.9 ± 2.823.8 ± 3.60.4
BSA (m2)1.66 ± 0.221.62 ± 0.190.24
Serum creatinine (mg/dL)1.2 ± 0.31.3 ± 0.40.4
CAD risk factors
Hypertension421 (39.1)313 (34 )0.32
Diabetes mellitus358 (33.2)268 (29 )0.29
Smokers323 (30)323 (35 )0.31
Family history of CAD76 (7.1)37 (4 )0.43
Dyslipidemia441 (41)335 (36.4 )0.22
Clinical diagnosis
Acute coronary syndrome676 (62.8)543 (58.9)0.12
Chronic stable angina355 (33)240 (26.1)0.32
Cardiomyopathy07 (0.6)38 (4.1)0.05
Chest pain for evaluation27 (2.5)46 (4.9)0.53
Previous CABG07 (0.6)31 (3.3)0.04
Valvular heart disease4 (0.3)23 (2.4)0.02
LVEF (%)
 (a) >45%818 (76)646 (70.2)0.32
 (b) 35–45%120 (11.2)154 (16.7)0.21
 (c) <35%138 (12.8)120 (13.1 )0.4
Medications
Aspirin1002 (93.2)708 (76.9)0.5
Clopidogrel55 (50.6)636 (69.1)0.3
Prasugrel132 (12.3)169 (18.4)0.11
Ticagrelor58 (5.8)29 (3.2)0.33
Statin981 (91.2)722 (78.4)0.7
Beta-blocker785 (72.9)620 (67.4)0.53
ACEI/ARB974 (90.5)754 (81.9)0.19
CCB230 (21.4)268 (29.2)0.5
Aldosterone antagonist132 (12.3)84 (9.2)0.31
Angiographic severity of CAD (obstructive)743 (69.1)723 (78.6)0.42
 (a) SVD350 (47.2)420 (58.2)0.18
 (b) DVD212 (28.6)161 (22.2)0.56
 (c) TVD181 (20.4)104 (14.3)0.67
 (d) Left main (isolated ± other vessel)41 (3.8)38 (5.3 )0.3
CAD (intermediate 50–70%)177 (16.4)103 (11.2)0.29
Non-obs. CAD (recanalised)97 (8.9)38 (4.2)0.44
Normal coronaries59 (5.4)55 (6)0.31

Data presented as mean ± standard deviation or number (percentage). BMI = body mass index; BSA = body surface area; CAD = coronary artery disease; DM = diabetes mellitus; LVEF = left ventricular ejection fraction; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; CCB = calcium-channel blocker; SVD = single-vessel disease; DVD = double-vessel disease; TVD = triple-vessel; CABG = coronary artery bypass graft.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.